Login / Signup

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma.

Jeffrey WangJacqueline WangElyse LopezHui GuoHui ZhangYang LiuZhihong ChenShengjian HuangShouhao ZhouAngela LeemingR J ZhangDayoung JungHannah ShiHadley GrundmanDarian DoakesKathleen CuiChangying JiangMakhdum AhmedKrystle NomieBingliang FangMichael L WangYixin YaoLiang Zhang
Published in: Blood cancer journal (2019)
Keyphrases
  • diffuse large b cell lymphoma
  • cell proliferation
  • pi k akt
  • wild type
  • signaling pathway